JPS60188306A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JPS60188306A
JPS60188306A JP4354284A JP4354284A JPS60188306A JP S60188306 A JPS60188306 A JP S60188306A JP 4354284 A JP4354284 A JP 4354284A JP 4354284 A JP4354284 A JP 4354284A JP S60188306 A JPS60188306 A JP S60188306A
Authority
JP
Japan
Prior art keywords
ascorbic acid
cosmetic
pyridoxine
tyrosinase
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4354284A
Other languages
Japanese (ja)
Inventor
Junko Kurakake
倉掛 順子
Kenzo Sato
建三 佐藤
Akira Akiyasu
秋保 暁
Yumiko Suzuki
裕美子 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP4354284A priority Critical patent/JPS60188306A/en
Publication of JPS60188306A publication Critical patent/JPS60188306A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:A cosmetic, containing pyridoxine or a derivative thereof with L- ascorbic acid and an ester thereof together, capable of remarkably improving liver-spot, ephelis, dark skin, etc., and having improved whitening and beautifying effect. CONSTITUTION:A cosmetic obtained by incorporating one or two or more selected from L-ascorbic acid having the ability to inhibit the action of tyrosinase or returning dark-colored oxidized form melanin to light-colored reduced form melanin and esters thereof with one or two or more selected from pyridoxine having the ability to inhibit the action of the tyrosinase and derivatives thereof, e.g. pyridoxal having aldehyde at the 4-position, at 1:10-10:1 compounding weight ratio. Preferably, >=0.001wt%, particularly about 10wt%, based on the cosmetic, L-ascorbic acid and >=0.001wt%, particularly about 5wt%, based on the cosmetic, pyridoxine are incorporated therein.

Description

【発明の詳細な説明】 本発明は、美白効果が著しく改良された新規な化粧料に
関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel cosmetic with significantly improved whitening effects.

皮膚美白剤を配合した化粧料はじみやそばかすの原因と
なる日焼けした皮膚などを美白する為に主として使用さ
れており、化粧料のなかでも消費者の関心が非常に高い
ものである。
Cosmetics containing skin whitening agents are mainly used to whiten sunburned skin, which causes blemishes and freckles, and are of great interest to consumers among cosmetics.

ビ゛ アスコルiン酸はチロシンからメラニンを生成するチロ
シナーゼの作用を阻害し、又、生成している濃色酸化型
メラニンを淡色還元型メラニンに戻す作用を有し、皮膚
の美白化、しみ、そばがす黒皮症、肝煎等の治療、改善
に有効な化合物であることは周知であるが・熱や光に対
して極めて不安定で酸化され易い性質を有し、特に水分
を含有する化粧料中においては分解し易く、着色を招き
易い。そのためアスコルビン酸を安定化する目的ビ でアスコルiン酸を高級脂肪酸やりん酸のエステル体と
して配合したり、抗酸化剤もしくは還元剤を使用添加す
ることが提案されているが、アスコビ ル暑ン酸を安定化すればする程、美白効果が薄れ−一ご
1 配合量を増せ≠皮膚刺激が出現するといった問題点があ
った。
Biascoric acid inhibits the action of tyrosinase, which generates melanin from tyrosine, and also has the effect of returning the dark oxidized melanin to the light reduced melanin, resulting in skin whitening, age spots, and It is well known that it is an effective compound for the treatment and improvement of buckwheat melasma, melasma, etc.; however, it is extremely unstable to heat and light and easily oxidized, and is especially effective against cosmetics containing water. It easily decomposes in food and tends to cause coloring. Therefore, for the purpose of stabilizing ascorbic acid, it has been proposed to blend ascorbic acid as an ester of higher fatty acids or phosphoric acid, or to add an antioxidant or reducing agent. The more stabilized the skin whitening effect, the less the whitening effect becomes.

本発明者らは、こうした事情にかんがみ、真に優れた美
白効果を有する化粧料を得るべく鋭意研究を重ねた結果
、ピリドキシンまたはその誘導体に、チロシンからメラ
ニンを生成するチロシナーゼの作用を阻害する働きがあ
ること、その阻害効果はL−アスコルビン酸またはその
誘導体と併用することにより増強し、しみ、そばかす、
色黒などが著しく改善されることを見出し、これらの知
見にもとづいて本発明を完成するに至った。
In view of these circumstances, the present inventors have conducted intensive research to obtain cosmetics with truly excellent whitening effects, and have found that pyridoxine or its derivatives have the ability to inhibit the action of tyrosinase, which generates melanin from tyrosine. Its inhibitory effect can be enhanced by using it in combination with L-ascorbic acid or its derivatives, and it can reduce age spots, freckles,
It was discovered that dark skin and the like were significantly improved, and the present invention was completed based on these findings.

即ち、本発明は、L−アスコルビン酸およびそのエステ
ルよりなる群から選ばれた1種又は2種以上と、ピリド
キシンお」:びその誘導体からなる群より選ばれた1種
又CJ2種以−1−とを、含有することを特徴とする美
白化粧刺である。
That is, the present invention provides one or more selected from the group consisting of L-ascorbic acid and its esters, one selected from the group consisting of pyridoxine and its derivatives, or two or more CJ-1- It is a whitening cosmetic product characterized by containing the following.

次に本発明の構成について述べる。Next, the configuration of the present invention will be described.

本発明に使用するL−アスコルビン酸は、一般にビタミ
ンCといわれ、その強い還元作用により細胞呼吸作用、
酵素賦活作用、膠原形成作用を有し、かつメラニン還元
作用を有する。又、L−アスコルビン酸エステルとして
は、例えば、L−アスコルビン酸モノステアレー1・、
L−アスコルビン酸モノパルミテ−1・、L−アスコル
ビン酸モノオレート等のL−アスコルビン酸モノアルキ
ルエステル類、L−アスコルビン酸モノリン酸エステル
、L−アスコルビン酸−2−硫酸の」:うなL−アスコ
ルビン酸モノエステル誘導体、L−アスコビン酸ジステ
アレ−1・、L−アスコルビン酸ジパデ ルミ≠−ト、L−アスコルビン酸ジオレート等のL−ア
スコルビン酸ジアルキルエステル類、L−アスコルビン
酸シリン酸エステルのようなL−アスコルビン酸ジエス
テル誘導体、L−アスコルビン酸トリステアレート、L
−アスコルビン酸トリ條 パルミテート、L−アスコルビン養トリオレート等のト
リアルキルエステル類、L−アスコルビン酸トリリン酸
エステル等の ゛ − ±母母アスコルビン酸トリエステルFA 導体等をあげ
ることができる。
L-ascorbic acid used in the present invention is generally referred to as vitamin C, and its strong reducing action has a cellular respiration effect.
It has an enzyme activation effect, a collagen formation effect, and a melanin reduction effect. In addition, examples of L-ascorbic acid esters include L-ascorbic acid monostearate 1.
L-ascorbic acid monoalkyl esters such as L-ascorbic acid monopalmite-1. L-ascorbic acid such as ester derivatives, L-ascorbic acid dialkyl esters such as L-ascorbic acid distearate-1, L-ascorbic acid dipadermite, L-ascorbic acid dioleate, L-ascorbic acid syric acid ester Diester derivative, L-ascorbic acid tristearate, L
Examples include trialkyl esters such as -ascorbic acid trispalmitate and L-ascorbic acid triphosphate, and ascorbic acid triester FA conductors such as L-ascorbic acid triphosphate.

本発明の化粧料には上記したL−アスコルビン酸および
そのエステルからなる群より〕2種又は2種以」二が適
宜選択され使用される。
In the cosmetic composition of the present invention, two or more than two types are suitably selected and used from the group consisting of the above-mentioned L-ascorbic acid and its esters.

L−アスコルビン酸又はL−アスコルビン酸エステルは
、化粧料中に0001重量%以上配合すると効果があら
れれ、本発明の効果を発揮するためには10重量%程度
で十分である・ 本発明に用いるピリ1゛キシは、一般にビタミンB6と
いわれ、抗皮膚炎性因子、微生物の成長促進因子とされ
ている。
L-ascorbic acid or L-ascorbic acid ester is effective when incorporated in cosmetics at 0001% by weight or more, and about 10% by weight is sufficient to exhibit the effects of the present invention. Used in the present invention Vitamin B6 is generally referred to as vitamin B6, and is considered to be an anti-dermatitis factor and a growth promoting factor for microorganisms.

基のピリドキシンおよびそれらのリン酸エステルおよび
塩酸塩などの各種塩類があげられる。
Examples include the basic pyridoxine and various salts thereof such as phosphate esters and hydrochlorides.

本発明の化粧料1sおいては上記したピリドキシンおよ
びその誘導体からなる群より1種又は2種以上が適宜選
択され使用される。
In the cosmetic 1s of the present invention, one or more of the above-mentioned pyridoxine and its derivatives are appropriately selected and used.

ピリドキシンまたはその誘導体は、化粧ri中に000
1重量%以上配合すると効果があられれ、本発明の効果
を発揮するためには、5取量%程度で十分である。
Pyridoxine or its derivatives are used during cosmetic ri.
The effect is obtained when the content is 1% by weight or more, and about 5% by weight is sufficient to exhibit the effects of the present invention.

L−アスコルビン酸又はL−アスコルビン酸エステルと
、ピリドキシン又はその誘導体との配合比は重量比で1
 ]0〜]0:1が好ましい。
The blending ratio of L-ascorbic acid or L-ascorbic acid ester and pyridoxine or its derivative is 1 by weight.
]0 to ]0:1 is preferred.

Oa、下余白) 本発明の化粧料には、上記の必須成分の他に、通常化粧
料に配合される成分、例えば、紫外線吸収剤、湿潤剤、
防腐剤、界面活性剤、香料、色素等を本発明の効果を損
わない範囲で適宜組合わせ、使用することができる。
Oa, lower margin) In addition to the above-mentioned essential ingredients, the cosmetic of the present invention also contains ingredients that are usually included in cosmetics, such as ultraviolet absorbers, humectants,
Preservatives, surfactants, fragrances, pigments, and the like can be used in appropriate combinations within a range that does not impair the effects of the present invention.

次に実施例をあげて本発明をさらに詳細に説明する。本
発明はこれにより限定されるものではない・配合料は重
量%である。
Next, the present invention will be explained in more detail with reference to Examples. The present invention is not limited thereby. The ingredients are in weight percent.

lぐ なお、美白効果は、ドーミから黒褐色色素メラニンを生
成するチロシナーゼの作用を阻害する割合で示すいわゆ
るチロシナーゼ活性阻害率と、累積塗布による皮膚に対
する色白効果、シミ・ソバカスの解消などの使用テスト
の2点から判定した。
Note that the whitening effect is determined by the so-called tyrosinase activity inhibition rate, which is the rate of inhibiting the action of tyrosinase that produces the dark brown pigment melanin from Domi, and the skin whitening effect of cumulative application, and the results of usage tests such as the elimination of age spots and freckles. Judgment was made from two points.

くチロシナーゼ活性阻害実験〉 ノψ L−ドーミを基質としチロシナーゼを25°C115分
間作用させ生成するメラニンの中間体であるド4ワタ 一バクロムを*追1’1mで、吸光光度計により測定す
る方法で行った。反応液組成、判定方法を以下に示す。
Tyrosinase Activity Inhibition Experiment> A method in which tyrosinase, which is an intermediate of melanin, is produced by using L-domi as a substrate and acting on tyrosinase for 115 minutes at 25°C.Measurement method using an absorptiometer at a distance of 1'1 m. I went there. The reaction solution composition and determination method are shown below.

(反応液組成) L−dopa O,5mg /ml 0.5 mlリン
酸緩衝液(p)l−h8=) 0.9 mノ試料溶液 
0o5− チロシナーゼ(マッシ、/l/−ム)(1mg/m) 
0.05m1(500unit/m/! ) (判定) ◎:チロシナーゼ阻害率 ’70%以」二〇’ 5゜〜
7o% △:20〜50% ×:2o1%以下 く累積塗布による美白効果試験〉 (試験方法) 色黒、しみ、そばかす等に悩む被試験者、1群加名とし
て・1つの試料ローションを朝夕、3ケ月間、毎日顔面
に塗布し、3ケ月目にその美白効果を調べた。
(Reaction solution composition) L-dopa O, 5 mg/ml 0.5 ml phosphate buffer (p)l-h8=) 0.9 m sample solution
0o5- Tyrosinase (massi, /l/-mu) (1mg/m)
0.05m1 (500unit/m/!) (Judgment) ◎: Tyrosinase inhibition rate '70% or more'20' 5° ~
7o% △: 20-50% ×: 2o1% or less Whitening effect test by cumulative application〉 (Test method) Test subjects suffering from dark skin, spots, freckles, etc., as 1 group ・One sample lotion applied morning and evening It was applied to the face every day for 3 months, and its whitening effect was examined after the 3rd month.

(判定基準) 著 効:色素沈着がほとんど目立たなくなった。(Judgment criteria) Author: Effect: Pigmentation is almost invisible.

有 効:非常にうずくなった。Effective: Very tingling.

やや有効:ややうずくなった。Slightly effective: Slightly tingling.

無 効:変化なし。Ineffective: No change.

(判定) ◎:被試験者のうち著効、有効の示す割合(有効率)が
80%以上の場合 0・ 50%〜80%の場合 × : 50%以下の場合 実施例1〜3、比較例1〜3について述べる・表1の配
合組成よりなるローションを調整し、そのチロシナーゼ
活性阻害効果および累積塗布による美白効果について調
べた。
(Judgment) ◎: 0 if the percentage of test subjects showing excellent response or efficacy (effective rate) is 80% or more. ×: 50% to 80%: Examples 1 to 3, comparison if 50% or less. Examples 1 to 3 will be described. A lotion having the composition shown in Table 1 was prepared, and its tyrosinase activity inhibiting effect and whitening effect upon cumulative application were investigated.

製法は以下の方法で調整した。即ち95%エチルアルコ
ール]0りに、 POE (20)ラウIJ /l/ 
ニーf ル0.5りおよび香料を混合し、次いでこの中
にあらかじめグリセリン29とプロピレングリコール1
りと、クエン酸0.29.l−アスコルビン酸又はその
エステル、及びピリドキシン、またはその誘導体とを加
え・さらに、蒸留水を全重量が1007になる様に必要
量を添加し混合して調整した; (以下余白) 表1 表1から明らがなように、本発明の化粧料は美白効果に
優れる新規な化粧料である。
The manufacturing method was adjusted as follows. i.e. 95% ethyl alcohol]0, POE (20) Rau IJ /l/
Mix 0.5 liters of powder and fragrance, and then add 29 parts of glycerin and 1 part of propylene glycol to the mixture.
and citric acid 0.29. l-Ascorbic acid or its ester, and pyridoxine or its derivative were added, and the necessary amount of distilled water was added and mixed so that the total weight was 1007; (the following is the margin) Table 1 Table 1 As is clear from the above, the cosmetic of the present invention is a novel cosmetic with excellent whitening effects.

実施例4 乳 液 つぎの処方に従い、常法により乳液を製造した。Example 4 Milk liquid A milky lotion was produced by a conventional method according to the following recipe.

(重量%) ステアリン酸 20 セタノール ]0 ワセリン 30 ラノリンアルコール 20 流動パラフイン 80 スクワラン 3゜ エス力ロール507 2.0 アスコルビン酸−2−硫酸Na O,1ピリドキシン 
0.01 p、 0. E、 (1,0% ル) % ノオL= 
−ト2.5トリエタノールアミン 1゜ プロピレングリコール 5゜ 香 料 適 量 防腐剤 適 量 蒸留水 7o39 実施例5 栄養クリーム つぎの処方に従い、常法によりクリームを製造した0 (重量%) ステアリン酸 2.0 ステアリルアルコール 70 還元ラノリン 2−0 スクワラン 50 オクチルドデカノール 60 P、0. E、 (25モル)セチルエーテル 30親
油型モノステアリン酸グリセリン 2−0香 料 適 
量 防腐剤 適 量 プロピレングリコール 5.0 アスコルビン酸シリン酸エステル 30アスコルビン酸
ジオレー1− 2−0 塩酸ピリドキシン 0.25 ピリドキシン 025 蒸留水 62.5 実施例6 パック つぎの処方に従い、常法によりパックを製造した。
(Weight %) Stearic acid 20 Setanol ] 0 Vaseline 30 Lanolin alcohol 20 Liquid paraffin 80 Squalane 3゜S-Rolol 507 2.0 Ascorbic acid-2-sulfate Na O,1 Pyridoxine
0.01p, 0. E, (1,0% Le) % Noor L=
-2.5 Triethanolamine 1゜Propylene glycol 5゜Fragrance Appropriate amount Preservative Appropriate amount Distilled water 7o39 Example 5 Nutritional cream A cream was produced by a conventional method according to the following recipe.0 (% by weight) Stearic acid 2 .0 Stearyl alcohol 70 Reduced lanolin 2-0 Squalane 50 Octyldodecanol 60 P, 0. E, (25 mol) Cetyl ether 30 Lipophilic glyceryl monostearate 2-0 Fragrance suitable
Amount Preservative Appropriate amount Propylene glycol 5.0 Ascorbic acid silicate ester 30 Ascorbic acid diolet 1-2-0 Pyridoxine hydrochloride 0.25 Pyridoxine 025 Distilled water 62.5 Example 6 Pack The pack was prepared in a conventional manner according to the following recipe. Manufactured.

(重量%) カメリン ’10.095 クルク 19.0 プロピレングリコール 50 酢酸カルシウム 001 尿 酸 05 アスフルビン酸モノパルミテート0.005ビリドキザ
ール 50 香 料 0.39 (以下余白) 実施例7 化粧水 つぎの処方に従い・常法により化粧水を製造した。
(Weight %) Camerin '10.095 Curku 19.0 Propylene glycol 50 Calcium acetate 001 Uric acid 05 Asfulvic acid monopalmitate 0.005 Viridoxal 50 Fragrance 0.39 (Left below) Example 7 Lotion Follow the following formulation - A lotion was manufactured using a conventional method.

(重量%) エタノール 150 P、 O,E、 (20モル)オレイル 08アルコー
ルエーテル 2−ヒドロキシ−4−メトキシ 01 ベンゾフエノン クエン酸 0.05 クエン酸ソーダ 006 L−アスコルビン酸 005 ピリドキシン 0005 グリセリン 50 香 料 適量 防腐剤 適量 蒸留水 ’78.935 実施例4〜7より得られた化粧料はチロシナーゼ活性阻
害効果に優れ、また累積塗布による美白効果に優れてい
た。
(% by weight) Ethanol 150 P, O, E, (20 mol) Oleyl 08 Alcohol ether 2-hydroxy-4-methoxy 01 Benzophenone citric acid 0.05 Sodium citrate 006 L-ascorbic acid 005 Pyridoxine 0005 Glycerin 50 Fragrance Ingredients Appropriate amount Preservative Appropriate amount Distilled water '78.935 The cosmetics obtained from Examples 4 to 7 were excellent in the tyrosinase activity inhibiting effect and also had an excellent whitening effect when applied cumulatively.

特許出願人 株式会社 資生堂Patent applicant Shiseido Co., Ltd.

Claims (1)

【特許請求の範囲】[Claims] L−アスコルビン酸おコニびそのエステルよりなる群か
ら選ばれた1種又は2種以上と、ピリドキシンおよびそ
の誘導体からなる群より選ばれた1種又は2種以上とを
、含有することを特徴とする化粧料。
It is characterized by containing one or more selected from the group consisting of L-ascorbic acid and its esters, and one or more selected from the group consisting of pyridoxine and its derivatives. Cosmetics.
JP4354284A 1984-03-07 1984-03-07 Cosmetic Pending JPS60188306A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4354284A JPS60188306A (en) 1984-03-07 1984-03-07 Cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4354284A JPS60188306A (en) 1984-03-07 1984-03-07 Cosmetic

Publications (1)

Publication Number Publication Date
JPS60188306A true JPS60188306A (en) 1985-09-25

Family

ID=12666627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4354284A Pending JPS60188306A (en) 1984-03-07 1984-03-07 Cosmetic

Country Status (1)

Country Link
JP (1) JPS60188306A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100581374B1 (en) * 1999-04-22 2006-05-24 주식회사 엘지생활건강 Composition of cosmetics comprising effect of improving subdued skin color
JP2007509899A (en) * 2003-11-06 2007-04-19 ユニリーバー・ナームローゼ・ベンノートシヤープ Improved cosmetic composition comprising vitamin B3, vitamin B6 and an organic acid
JP2008013578A (en) * 2003-10-01 2008-01-24 Daiichi Fine Chemical Co Ltd Cosmetic composition
JP2017123833A (en) * 2016-01-12 2017-07-20 共栄化学工業株式会社 Composition
WO2023149225A1 (en) * 2022-02-03 2023-08-10 株式会社 資生堂 Skin care composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5543443A (en) * 1978-09-22 1980-03-27 Ricoh Elemex Corp Battery wrist watch
JPS58180409A (en) * 1982-04-16 1983-10-21 Shiseido Co Ltd Cosmetic

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5543443A (en) * 1978-09-22 1980-03-27 Ricoh Elemex Corp Battery wrist watch
JPS58180409A (en) * 1982-04-16 1983-10-21 Shiseido Co Ltd Cosmetic

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100581374B1 (en) * 1999-04-22 2006-05-24 주식회사 엘지생활건강 Composition of cosmetics comprising effect of improving subdued skin color
JP2008013578A (en) * 2003-10-01 2008-01-24 Daiichi Fine Chemical Co Ltd Cosmetic composition
US8003615B2 (en) 2003-10-01 2011-08-23 Daiichi Fine Chemical Co., Ltd. Stable vitamin B6 derivative
JP2007509899A (en) * 2003-11-06 2007-04-19 ユニリーバー・ナームローゼ・ベンノートシヤープ Improved cosmetic composition comprising vitamin B3, vitamin B6 and an organic acid
US7332152B2 (en) 2003-11-06 2008-02-19 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic composition
JP2017123833A (en) * 2016-01-12 2017-07-20 共栄化学工業株式会社 Composition
WO2023149225A1 (en) * 2022-02-03 2023-08-10 株式会社 資生堂 Skin care composition

Similar Documents

Publication Publication Date Title
US5747006A (en) Skin whitener composition containing acerola cherry fermentate
JP2502318B2 (en) Whitening cosmetics
US3887701A (en) Antibacterial oral compositions containing preservative-antioxidants
US6641845B1 (en) Skin whitening composition comprising bearberry and tetrahydrocurcumin
JP2000095663A (en) Agent for external use containing plant extract
JPS61155302A (en) Skin color-lightening cosmetic
JP3135943B2 (en) Whitening agent
JPH07316034A (en) Method of using resorcinol derivative mono-or di-substitutedat 4,4-and 5-,or 4-and 6-positions for cosmetic composition or dermal medicinal composition having depigmentation action
JPS63188609A (en) External preparation preventing coloring
JP2000212082A (en) Preparation for external use for skin
JPH0899820A (en) Skin external agent
JP2001288035A (en) External preparation for skin for acne
JP2903240B2 (en) External preparation for skin
JPH09157153A (en) Preparation for external use for skin
JPH0418010A (en) W/o/w type emulsified cosmetic
JPS60188306A (en) Cosmetic
JPH05213736A (en) Skin cosmetic
JP2578394B2 (en) Whitening agent
JP2814549B2 (en) Oral composition
JP2002370962A (en) Bleaching preparation and cosmetic for preventing and improving aging of skin
JPS6270309A (en) Skin beautifying cosmetic
JPS61194008A (en) Cosmetic
JP2565516B2 (en) Topical skin
JP3380261B2 (en) Cosmetics
JP2753639B2 (en) Cosmetics